Recurrent Germline Mutations of CHEK2 as a New Susceptibility Gene in Patients with Pheochromocytomas and Paragangliomas

Figure 1

The germline CHEK2 mutations detected by Sanger sequencing of these four patients. The red arrows indicate the mutation sites, (a) for Patient 1, (b) for Patient 2, (c) for Patient 3, and (d) for Patient 4.

(a)

(b)

(c)

(d)